
News|Podcasts|December 23, 2024
Pharmacy Focus: Oncology Edition – Key Insights and Interviews From the 2024 SABCS Meeting
Author(s)Alexandra Gerlach, Associate Editor
Pharmacy Times attended the 2024 San Antonio Breast Cancer Symposium from December 10 to December 13.
Advertisement
This episode of Pharmacy Focus: Oncology Edition highlights key insights from the 2024 San Antonio Breast Cancer Symposium, covering new FDA-approved therapies, dose optimization strategies, and innovative prevention approaches in breast cancer care.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Approves Lerodalcibep for Hypercholesterolemia and Heterozygous Familial Hypercholesterolemia
2
Once-Weekly Retatrutide Reduces Weight and Knee Pain in Patients With Obesity and Osteoarthritis
3
2025 FDA Approvals Highlight the Growing Role of Biomarkers in Breast Cancer
4
SABCS 2025 Roundup: Advancing Therapy and Precision Care in Breast Cancer
5

















































































































































































































